<scp>HIV</scp> incidence in <scp>US</scp> first‐time blood donors during 12 and 3 month deferral policy periods between 2015 and 2023 before implementation of individual donor assessment
HIV incidence in FTD did not increase between 2015 and 2023. An overall decline in HIV incidence in the 3 m deferral period compared with the 12 m deferral period was evident. These results provide no indication of an increased residual risk of transfusion-transmitted HIV from FTD in the United States with the reduced deferral periods.
Authors
- Barbee Whitaker (ORCID: https://orcid.org/0000-0002-6311-6268)
- Rita Reik (ORCID: https://orcid.org/0000-0001-7345-129X)
- Jed B. Gorlin (ORCID: https://orcid.org/0000-0002-3630-372X)
- Artur Belov (ORCID: https://orcid.org/0000-0001-6848-1224)
- Eduard Grebe (ORCID: https://orcid.org/0000-0001-7046-7245)
- Brian Custer (ORCID: https://orcid.org/0000-0001-6251-366X)
- Mars Stone (ORCID: https://orcid.org/0000-0001-5619-2767)
- Edward P. Notari (ORCID: https://orcid.org/0000-0002-9505-3628)
- Michael Paul Busch (ORCID: https://orcid.org/0000-0002-1446-125X)
- Clara Di Germanio (ORCID: https://orcid.org/0000-0002-6047-211X)
- Marion C. Lanteri (ORCID: https://orcid.org/0000-0002-4213-5013)
- Susan L. Stramer (ORCID: https://orcid.org/0000-0002-5865-6366)
- Hong Yang (ORCID: https://orcid.org/0000-0002-0057-6566)
- Benyam Hailu
- Jahnavi Reddy Bashkar
- Venkata Dayana
Institutions
- National Institutes of Health (US)
- United States Food and Drug Administration (US)
- New York Blood Center (US)
- American Red Cross (US)
- University of California, San Francisco (US)
- Pacific Research Institute (US)
- National Heart, Lung, and Blood Institute (US)
- Vitalant (US)
- OneBlood (US)
Publication Details
- Journal
- Transfusion
- Published
- 2025-04-13
- DOI
- https://doi.org/10.1111/trf.18195
- Citations
- 6
- Primary Topic
- Blood donation and transfusion practices
- Type
- article
- Field-Weighted Citation Impact
- 16.56
Funders
- U.S. Department of Health and Human Services
- National Institutes of Health
- U.S. Food and Drug Administration
- Office of the Assistant Secretary for Health
- National Heart, Lung, and Blood Institute